Completed
AeroEclipse II Agreement
NCT01288482
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,740 public trials
644 recruiting studies
Hypersensitivity trial results
NCT01783028
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Public Health - Seattle & King County Seattle, Washington, United States
NCT02133053
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
Not specified
NCT01451541
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
- Locations
-
- Burke Pharmaceutical Research Hot Springs, Arkansas, United States
- Arkansas Pediatric Clinic Little Rock, Arkansas, United States
- West Coast Clinical Trials, LLC Costa Mesa, California, United States
- Premier Health Research Center Downey, California, United States
Completed
Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis
NCT02131051
- Conditions
- Allergic Rhinoconjunctivitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- HNO Praxis Elmshorn Elmshorn, Germany
NCT01620099
- Conditions
- Asthma, Behavior, Bronchial Diseases, +11 more
- Locations
-
- Hospital Grosshansdorf Großhansdorf, Germany
- Research Centre on Asthma and COPD, University of Ferrara Ferrara, Italy
NCT02130440
- Conditions
- Airway Obstruction, Hypersensitivity, Hypersensitivity, Immediate, +24 more
- Locations
-
- Second University of Naples Naples, Italy
NCT01316315
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
- Duke Asthma, Allergy and Airway Center Durham, North Carolina, United States
NCT01311661
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 1222.29.11006 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
- 1222.29.11001 Boehringer Ingelheim Investigational Site Centennial, Colorado, United States
- 1222.29.11012 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
- 1222.29.11002 Boehringer Ingelheim Investigational Site Overland Park, Kansas, United States
Completed
Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
NCT01987765
- Conditions
- Conjunctival Diseases, Conjunctivitis, Conjunctivitis, Allergic, +4 more
- Locations
-
- Gangwon-do, South Korea